MXEQX
Price
$29.98
Change
+$1.92 (+6.84%)
Updated
Apr 9 closing price
Net Assets
1.49B
RMFCX
Price
$53.56
Change
+$3.33 (+6.63%)
Updated
Apr 9 closing price
Net Assets
98.3B
Ad is loading...

MXEQX vs RMFCX

Header iconMXEQX vs RMFCX Comparison
Open Charts MXEQX vs RMFCXBanner chart's image
Empower Large Cap Value I
Price$29.98
Change+$1.92 (+6.84%)
VolumeN/A
Net Assets1.49B
American Funds American Mutual R3
Price$53.56
Change+$3.33 (+6.63%)
VolumeN/A
Net Assets98.3B
MXEQX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXEQX vs. RMFCX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEQX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.3B vs. MXEQX (1.49B). RMFCX pays higher dividends than MXEQX: RMFCX (1.34) vs MXEQX (0.06). MXEQX was incepted earlier than RMFCX: MXEQX (30 years) vs RMFCX (23 years). MXEQX (0.98) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 31.00 vs. MXEQX (29.00). MXEQX has a lower initial minimum investment than RMFCX: MXEQX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : -4.43 vs. MXEQX (-8.18). MXEQX return over 5 years is better than : 62.90 vs. RMFCX (45.42).
MXEQXRMFCXMXEQX / RMFCX
Total Expense Ratio0.960.91105%
Annual Report Gross Expense Ratio0.980.91108%
Fund Existence30 years23 years-
Gain YTD-9.014-7.697117%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B98.3B2%
Annual Yield % from dividends0.061.345%
Returns for 1 year-8.18-4.43185%
Returns for 3 years2.07-0.65-319%
Returns for 5 years62.9045.42138%
Returns for 10 years51.4446.29111%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGHT2.350.26
+12.44%
Sight Sciences
REVG31.552.69
+9.32%
REV Group
CSGP78.735.50
+7.51%
CoStar Group
PFSI94.482.07
+2.24%
PennyMac Financial Services
BRNS0.69-0.03
-3.69%
Barinthus Biotherapeutics plc